Emergency Medicine
Adult Diabetic Ketoacidosis
Adult diabetic ketoacidosis requires immediate recognition of insulin deficiency, volume depletion, electrolyte derangement, and its precipitant. This review focuses on rapid diagnostic confirmation, diabetes-type reassessment, safe insulin-dependent care, and prevention of recurrent hyperglycemic crises using currently supplied evidence.
Immediate assessment
Treat suspected DKA as an insulin-deficient emergency
DKA should trigger simultaneous stabilization, biochemical assessment, and cause-directed evaluation.
DKA reflects clinically consequential insulin deficiency with hyperglycemia, ketonemia, dehydration, acidemia, and electrolyte disturbance. It is classically associated with type 1 diabetes but can occur in insulinopenic type 2 diabetes, ketosis-prone type 2 diabetes, acute illness, missed insulin, and sodium-glucose cotransporter 2 inhibitor exposure. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
The supplied sources do not provide a complete adult DKA fluid, insulin infusion, potassium replacement, bicarbonate, or transition-to-subcutaneous-insulin protocol. Therefore, institutionally approved hyperglycemic-crisis pathways and current specialty guidance should govern acute resuscitation and monitoring rather than extrapolation from the diabetes-management sources reviewed here. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Obtain plasma glucose and assess for hyperglycemic crisis; a random plasma glucose of at least 200 mg/dL with classic hyperglycemic symptoms or crisis meets diagnostic criteria for diabetes. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Obtain A1C when clinically useful to estimate antecedent glycemia; it does not replace acute glucose-based assessment in a hyperglycemic crisis. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Identify likely precipitants, including insulin interruption, infection or other acute illness, myocardial infarction, glucocorticoids, second-generation antipsychotics, and SGLT2 inhibitor use. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Document diabetes type and home insulin regimen early; in established type 1 diabetes, basal insulin must not be interrupted. PubMedPubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIH
| Finding | Clinical implication | Next action |
|---|---|---|
| Classic hyperglycemic symptoms or hyperglycemic crisis with random plasma glucose ≥200 mg/dL | Diabetes is established clinically. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... | Treat the crisis and determine whether the patient has absolute or relative insulin deficiency. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... |
| Adult with weight loss, ketoacidosis, marked hyperglycemia, younger age, or low BMI | Features favor autoimmune type 1 diabetes but no single feature is definitive. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... | Order GAD antibody; if negative and suspicion remains, add IA-2 and/or ZnT8 antibodies where available. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... |
| Insulin-treated adult with persistent uncertainty about diabetes type | C-peptide may clarify endogenous insulin secretion. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... | Use a random C-peptide with concurrent glucose within 5 hours of eating; avoid testing within 2 weeks after a hyperglycemic emergency. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... |
| Obesity or metabolic syndrome with DKA | Does not exclude type 1 diabetes; ketosis-prone type 2 diabetes is also possible. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... | Maintain insulin until classification and insulin requirement are clear. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... |
Diagnostic reasoning
Reassess diabetes type after initial stabilization
Misclassification can produce unsafe insulin withdrawal or delayed insulin initiation.
Diabetes classification is often uncertain at presentation. Type 1 diabetes can occur at any age, obesity does not exclude autoimmune diabetes, and approximately 40% of adults with newly diagnosed type 1 diabetes may initially be misdiagnosed as having type 2 diabetes. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
The most useful clinical features favoring type 1 diabetes are age younger than 35 years, BMI below 25 kg/m2, unintentional weight loss, ketoacidosis, and plasma glucose above 360 mg/dL at presentation. Family history, ketosis without acidosis, osmotic symptoms, and coexisting autoimmune disease are weaker discriminators. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
For adults with overlapping phenotypic features, standardized islet autoantibody testing is recommended. GAD is the preferred first test; if negative, IA-2 and/or ZnT8 antibodies should be considered where available. A negative antibody test does not exclude type 1 diabetes. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Consider pancreatic diabetes in patients with acute or chronic pancreatitis, pancreatic surgery, pancreatic neoplasia, or exocrine pancreatic insufficiency; these patients may have loss of both insulin and glucagon secretion. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Consider monogenic diabetes when diabetes begins in the first 6 months of life, when early-onset diabetes follows an autosomal dominant pattern, or when phenotype is atypical for type 1 and type 2 diabetes. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
In adults with suspected type 1 diabetes who are not receiving insulin, provide close monitoring and education so insulin can be started promptly if glycemia deteriorates. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
| Result or circumstance | Interpretation | Action |
|---|---|---|
| Random C-peptide ≥600 pmol/L (≥1.8 ng/mL) | Substantial endogenous insulin secretion; testing circumstances are less consequential. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... | Assess for type 2 diabetes, monogenic diabetes, or other nonautoimmune diabetes while integrating phenotype and autoantibody results. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... |
| Random C-peptide <80 pmol/L (<0.24 ng/mL) | Very low endogenous insulin secretion. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... | Treat as severe insulin deficiency; do not discontinue insulin. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... |
| C-peptide 200–600 pmol/L (0.6–1.8 ng/mL) | Usually consistent with type 1 diabetes or MODY, but may occur in insulin-treated type 2 diabetes. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... | Interpret with concurrent glucose, duration of diabetes, phenotype, and antibody testing. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... |
| Within 2 weeks of hyperglycemic emergency | Result may not be appropriate for classification. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... | Defer C-peptide testing until recovery. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ... |
Inpatient safety
Protect against recurrent ketosis during transitions of care
Insulin omission is a preventable driver of recurrent DKA in insulin-deficient diabetes.
For people with type 1 diabetes, uninterrupted basal insulin is essential to prevent hyperglycemia and ketoacidosis during hospitalization, fasting, and procedures. This requirement should be explicit in admission orders, perioperative plans, and handoffs. PubMedPubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIH
Inpatient self-management may be appropriate only for selected patients who can safely administer insulin, monitor glucose, count carbohydrates, and participate in decisions under supervision from clinicians knowledgeable in glycemic management. PubMedPubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIH
Hyperglycemia with DKA can also arise in type 2 diabetes during severe illness, insulin omission, or exposure to drugs including SGLT2 inhibitors. Because SGLT2 inhibitors can be associated with DKA, review these agents during every DKA evaluation. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Before stopping intravenous insulin or changing treatment intensity, verify that the patient has a viable subcutaneous insulin plan, access to insulin and supplies, and education on deterioration and ketone-risk symptoms; supplied sources support the need for uninterrupted basal insulin in type 1 diabetes but do not specify transition timing or dosing. PubMedPubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIH
If a personal insulin pump is used, unexplained persistent hyperglycemia should prompt assessment for infusion interruption or site failure; if glucose does not improve after a correction, use injected insulin and change the infusion site. PubMedPubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIH
Consider social and financial barriers to insulin, food, transportation, monitoring supplies, and follow-up. These barriers can impair self-management and increase acute complication risk. PubMedPubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIH
Prevention
Use follow-up to prevent the next hyperglycemic crisis
Recurrent DKA prevention depends on insulin access, skills, monitoring, and timely phenotype clarification.
Diabetes self-management education and support is a core element of diabetes care. CDC guidance emphasizes ongoing team-based support and notes that structured diabetes self-management education and support is associated with lower A1C and fewer complications. CDCCDCClinical Guidance for Diabetes
A1C monitoring frequency should reflect stability of therapy and glycemic control. CDC advises testing every 3 months when treatment has changed or goals are not met and every 6 months when treatment and glycemic goals are stable. CDCCDCYour Diabetes Care Schedule
For type 2 diabetes treated with metformin plus an SGLT2 inhibitor or GLP-1 agonist, ACP states that routine self-monitoring of blood glucose may be unnecessary in stable patients; this does not apply to insulin-dependent patients or those at risk for hypoglycemia or recurrent ketosis. PubMedPubMedNewer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians
At post-DKA review, reconcile all insulin products, injection or pump technique, access to glucose and ketone monitoring, and prescription affordability. PubMedPubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIH
Review sick-day and device-failure plans, including when to seek urgent care for persistent hyperglycemia, vomiting, dehydration, or suspected ketosis; the sources establish these as clinically relevant risks but do not specify a universal outpatient ketone threshold. PubMedPubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIH
Screen for psychosocial distress, depression, and barriers to care, especially after recurrent DKA or medication rationing. PubMedPubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIH
For adults with type 2 diabetes and inadequate control despite metformin and lifestyle measures, ACP recommends adding either an SGLT2 inhibitor or GLP-1 agonist; choose SGLT2 inhibitors preferentially with heart failure or chronic kidney disease and GLP-1 agonists when stroke risk or weight loss is a major priority. PubMedPubMedNewer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians
Evidence limitation
What the supplied evidence does not support
Avoid false precision when source material does not contain acute-care protocol details.
The provided search results include current diabetes diagnostic and classification guidance, longitudinal type 1 diabetes management, and general diabetes-care resources, but do not include a dedicated adult DKA consensus guideline or FDA labeling for insulin and adjunctive agents. Accordingly, they do not support publishing exact intravenous fluid choice or rate, insulin infusion dose, potassium replacement thresholds, bicarbonate criteria, phosphate therapy, anion-gap transition criteria, or ICU disposition thresholds. PubMed+1PubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIHDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Acute DKA care should therefore follow a current, locally adopted adult hyperglycemic-crisis protocol with endocrine and critical-care consultation as appropriate. Diabetes classification and recurrent-crisis prevention should proceed in parallel with acute stabilization. PubMed+1PubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIHDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Common questions
Can an adult with obesity and DKA still have type 1 diabetes?
Yes. Obesity does not exclude type 1 diabetes. In adults with DKA or an overlapping phenotype, evaluate clinical features, islet autoantibodies, and—after recovery when appropriate—C-peptide before reducing or discontinuing insulin. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
When should C-peptide be measured after DKA?
Do not measure C-peptide within 2 weeks of a hyperglycemic emergency. In insulin-treated patients with uncertain diabetes type, a random sample with concurrent glucose within 5 hours of eating can help classify endogenous insulin secretion after recovery. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Should basal insulin be held when an adult with type 1 diabetes is fasting or hospitalized?
No. Type 1 diabetes requires uninterrupted basal insulin to prevent hyperglycemia and ketoacidosis, including during hospitalization, fasting, and procedures. PubMedPubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIH
What diabetes medications should be reviewed in every DKA presentation?
Review all insulin access and adherence, recent glucocorticoids or second-generation antipsychotics, and SGLT2 inhibitor exposure. DKA can occur in insulinopenic type 2 diabetes and has been associated with SGLT2 inhibitor use. Diabetes JournalsDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
References
- Drug Dosing Recommendations for All Patients: A Roadmap ... — ascpt.onlinelibrary.wiley.com · ascpt.onlinelibrary.wiley.com
- Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians - PubMed — pubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
- Quality of Care in Adults With Diabetes - Diabetes in America - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- A review of the quality of current diabetes clinical practice guidelines - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Recent Updates to Clinical Practice Guidelines for Diabetes ... — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Introduction and Methodology: Standards of Care in Diabetes—2026 - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Type 2 diabetes in adults: management - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY - PubMed — pubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
- 6. Glycemic Goals and Hypoglycemia: Standards of Care in ... — www.ccjm.org · www.ccjm.org
- 16. Diabetes Care in the Hospital: Standards of Care in ... — www.ccjm.org · www.ccjm.org
- Diabetes - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Your Diabetes Care Schedule — www.cdc.gov · www.cdc.gov
- The Management of Type 1 Diabetes - Endotext - NCBI - NIH — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- 2. Classification and Diagnosis of Diabetes: Standards of ... — diabetesjournals.org · diabetesjournals.org
- Diagnosis and Classification of Diabetes Mellitus — diabetesjournals.org · diabetesjournals.org
- 2. Diagnosis and Classification of Diabetes: Standards of Care ... — diabetesjournals.org · diabetesjournals.org
- 2. Classification and Diagnosis of Diabetes — diabetesjournals.org · diabetesjournals.org
- NCT00081328 | Treatment Options for Type 2 Diabetes in ... — clinicaltrials.gov · clinicaltrials.gov
- Type 2 diabetes in adults: management | Guidance — www.nice.org.uk · www.nice.org.uk
- Overview | Type 1 diabetes in adults: diagnosis and management | Guidance | NICE — www.nice.org.uk · www.nice.org.uk
- Clinical Guidance for Diabetes — www.cdc.gov · www.cdc.gov
- Management of Diabetes — www.who.int · www.who.int
- Considerations for Blood Glucose Monitoring and Insulin Administration | Injection Safety | CDC — www.cdc.gov · www.cdc.gov